Regulatory multitasking of tolerogenic dendritic cells - lessons taken from vitamin d3-treated tolerogenic dendritic cells.
about
Dendritic cell-based approaches for therapeutic immune regulation in solid-organ transplantationGeneration of Tolerogenic Dendritic Cells and Their Therapeutic ApplicationsMetabolism Is Central to Tolerogenic Dendritic Cell FunctionThe dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape.Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis.Vitamin D regulates cytokine patterns secreted by dendritic cells to promote differentiation of IL-22-producing T cells.Laser-facilitated epicutaneous immunotherapy to IgE-mediated allergy.Tolerogenic dendritic cells and their applications in transplantationApoptotic cell-treated dendritic cells induce immune tolerance by specifically inhibiting development of CD4⁺ effector memory T cells.Cryopreserved vitamin D3-tolerogenic dendritic cells pulsed with autoantigens as a potential therapy for multiple sclerosis patients.It's time to bring dendritic cell therapy to type 1 diabetes.Interaction of the endocrine system with inflammation: a function of energy and volume regulation.Tissue specific heterogeneity in effector immune cell response.Immune modulation in humans: implications for type 1 diabetes mellitus.Vitamin D immunoregulation through dendritic cells.Tolerogenic dendritic cell therapy in organ transplantation.Diversity of immune cell types in multiple sclerosis and its animal model: Pathological and therapeutic implications.Dendritic cells treated with chloroquine modulate experimental autoimmune encephalomyelitis.Dendritic cell metabolism: immunity and toleranceRedox control of indoleamine 2,3-dioxygenase expression and activity in human monocyte-derived dendritic cells is independent of changes in oxygen tension.Translating Mechanism of Regulatory Action of Tolerogenic Dendritic Cells to Monitoring Endpoints in Clinical Trials.Regulating Immunogenicity and Tolerogenicity of Bone Marrow-Derived Dendritic Cells through Modulation of Cell Surface Glycosylation by Dexamethasone Treatment.Differential transcriptome of tolerogenic versus inflammatory dendritic cells points to modulated T1D genetic risk and enriched immune regulation.An antigen-specific semi-therapeutic treatment with local delivery of tolerogenic factors through a dual-sized microparticle system blocks experimental autoimmune encephalomyelitis.Autologous tolerogenic dendritic cells derived from monocytes of systemic lupus erythematosus patients and healthy donors show a stable and immunosuppressive phenotype.Tolerogenic Dendritic Cells from Poorly Compensated Type 1 Diabetes Patients Have Decreased Ability To Induce Stable Antigen-Specific T Cell Hyporesponsiveness and Generation of Suppressive Regulatory T Cells.Induction of human tolerogenic dendritic cells by 3'-sialyllactose via TLR4 is explained by LPS contamination.Shuttling Tolerogenic Dendritic Cells across the Blood-Brain Barrier In Vitro via the Introduction of De Novo C-C Chemokine Receptor 5 Expression Using Messenger RNA Electroporation.Cow's Milk and Immune Function in the Respiratory Tract: Potential Mechanisms.Regulation of CYP27B1 and CYP24A1 hydroxylases limits cell-autonomous activation of vitamin D in dendritic cells.Co-Stimulation-Impaired Bone Marrow-Derived Dendritic Cells Prevent Dextran Sodium Sulfate-Induced Colitis in Mice.
P2860
Q21284774-449B8897-2F11-4107-9823-E8AD22145BECQ26764855-7591150E-F652-42BC-8E39-1597E9EB3356Q26765348-FB61A08E-8E6D-4758-8A92-0608419DC8B7Q30317628-F8820F2A-71AF-47A4-89CF-2A8D5067EC66Q35597747-B1C21107-B84C-4D42-85B3-667F3558223AQ35673174-A6419965-BE8C-4AA0-8B18-C9F69EE408D4Q36033148-DBABEF55-2658-4D84-A413-DAA1AC95E526Q36302853-170CA973-40E3-416B-9305-B23803B61B1CQ36405155-F413942D-0EED-4E62-A797-B9398A7BF363Q36919825-C31F9007-3970-4B72-B8BF-C8F67C1A7E06Q37670174-A0424BB1-66F2-4E33-BFDA-D83654F8BE52Q37690138-E3F227FD-F68A-4BF7-B4F8-3CC9576B727CQ38132391-1D52DB10-D29A-4825-B82B-325E1E419F0EQ38182297-C9A7A104-E1E6-4172-9F64-7EB86AF19044Q38797005-C61FC050-DC07-45DB-917A-A0952708D5BDQ39013872-08781A77-B818-4084-8FB7-C1E94897057BQ39085433-1CC2F23A-87C4-4F68-9B0A-43039DB15F32Q41923517-97A2A184-4A53-4933-8013-FBC63D209F3EQ42551579-50567698-F8F3-46CE-98AA-FF45FC80B866Q44995189-B98E1A2B-04B5-47AF-9862-1F8E6148920FQ47128789-C241DDE2-9155-418F-A15B-99B6E7E1F778Q47325556-A8430DA2-0745-4AC7-A0C5-97A4E4964246Q47571105-3BE77EDD-BDFE-4431-B524-5F8578274A95Q47848180-28349653-7976-4783-AF16-00A96B5BAD90Q48004729-16A5693D-2447-4A00-A0D3-8415A20F190BQ48175684-AB47D1E5-BA64-4BB3-9EE8-316656A07DF9Q49557750-8BD8FCA7-D6C0-40E8-9E3A-AB84A81398D8Q49906660-424158A7-4B2C-4BAC-A8BB-A31212AE4B96Q50320976-880DB6EE-2D5F-473A-B4CF-9C40D69A0163Q53061723-A18E8F88-B658-467C-A20B-81F6C2519131Q55153552-D80F4757-79C8-4716-ACD3-4838A552DF3D
P2860
Regulatory multitasking of tolerogenic dendritic cells - lessons taken from vitamin d3-treated tolerogenic dendritic cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Regulatory multitasking of tol ...... d tolerogenic dendritic cells.
@en
type
label
Regulatory multitasking of tol ...... d tolerogenic dendritic cells.
@en
prefLabel
Regulatory multitasking of tol ...... d tolerogenic dendritic cells.
@en
P2860
P356
P1476
Regulatory multitasking of tol ...... d tolerogenic dendritic cells.
@en
P2093
Bart O Roep
Tatjana Nikolic
P2860
P356
10.3389/FIMMU.2013.00113
P577
2013-05-14T00:00:00Z